DalsnaFinance › IPOs › Immuneering › IPO
Immuneering Corp completed its initial public offering on NASDAQ on July 30, 2021, pricing at $15.00 a share.
| Ticker | IMRX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 30, 2021 |
| Offering price | $15.00 |
| Shares offered | 7,500,000 |
| Total raised | $113M |
Immuneering Corp sold 7,500,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $112.5 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $113 million total recorded for the deal.
Immuneering Corp — quote, profile and latest news →
Source: SEC EDGAR filings for Immuneering Corp. This page is general information, not investment advice.